0001388658-20-000149.txt : 20200708 0001388658-20-000149.hdr.sgml : 20200708 20200708201313 ACCESSION NUMBER: 0001388658-20-000149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200706 FILED AS OF DATE: 20200708 DATE AS OF CHANGE: 20200708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vort David A CENTRAL INDEX KEY: 0001670676 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37918 FILM NUMBER: 201019355 MAIL ADDRESS: STREET 1: C/O IRHYTHM TECHNOLOGIES, INC. STREET 2: 650 TOWNSEND STREET, SUITE 380 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iRhythm Technologies, Inc. CENTRAL INDEX KEY: 0001388658 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208149544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 BUSINESS PHONE: 415-632-5700 MAIL ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies, Inc. DATE OF NAME CHANGE: 20110429 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies Inc DATE OF NAME CHANGE: 20070201 4 1 wf-form4_159425357742940.xml FORM 4 X0306 4 2020-07-06 0 0001388658 iRhythm Technologies, Inc. IRTC 0001670676 Vort David A C/O IRHYTHM TECHNOLOGIES, INC. 699 8TH ST #600 SAN FRANCISCO CA 94103 0 1 0 0 EVP, Sales Common Stock 2020-07-06 4 M 0 11264 7.47 A 27267 D Common Stock 2020-07-06 4 S 0 5333 114.0275 D 21934 D Common Stock 2020-07-06 4 S 0 5931 114.6121 D 16003 D Employee Stock Option (right to buy) 7.47 2020-07-06 4 M 0 11264 0 D 2016-11-21 2025-07-21 Common Stock 11264.0 15657 D The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2020. This transaction was executed in multiple trades at prices ranging from $113.36 to $114.355 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $114.36 to $115.15 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This option is fully vested and exercisable in full. /s/ Christina Delfin, attorney in fact 2020-07-08